1. 68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case report. (June 2021) Authors: Tanriverdi, Ozgur; Tarimer, Mehmet L; Pak, Ceren D; Uylas, Selcuk; Alkan, Ali; Celik, Ozgur Ilhan; Kilic, Rabia M; Zeybek, Arife Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 4(2021) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗